Evidence map›Paper›PMID 26504594›Full record

ArticleJournal of ophthalmology2015

Lutein Leads to a Decrease of Factor D Secretion by Cultured Mature Human Adipocytes.

Yuan Tian, Aize Kijlstra, Johan Renes, Martin Wabitsch, Carroll A B Webers, Tos T J M Berendschot

Open access · goldAbstract read
In one paragraph

Article in Journal of ophthalmology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 89 citations in OpenAlex.

  1. Supplementing Diets withAnimals : an open access journal from MDPI · 2022
    Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Yuan TianUniversity Eye Clinic Maastricht, Postbus 5800, 6202 AZ Maastricht, Netherlands.
Aize KijlstraUniversity Eye Clinic Maastricht, Postbus 5800, 6202 AZ Maastricht, Netherlands.
Johan RenesDepartment of Human Biology, NUTRIM School for Nutrition, Toxicology and Metabolism, Maastricht University, Maastricht, Netherlands.
Martin WabitschSektion Pädiatrische Endokrinologie u. Diabetologie, Universität Ulm, Germany.
Carroll A B WebersUniversity Eye Clinic Maastricht, Postbus 5800, 6202 AZ Maastricht, Netherlands.
Tos T J M BerendschotUniversity Eye Clinic Maastricht, Postbus 5800, 6202 AZ Maastricht, Netherlands.
Maastricht University · NLUniversität Ulm · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose. Complement plays an important role in the pathogenesis of age related macular degeneration (AMD) and trials are currently being conducted to investigate the effect of complement inhibition on AMD progression. We previously found that the plasma level of factor D (FD), which is the rate limiting enzyme of the complement alternative pathway, was significantly decreased following lutein supplementation. FD is synthesized by adipose tissue, which is also the main storage site of lutein. In view of these findings we tested the hypothesis whether lutein could affect FD synthesis by adipocytes. Methods. A cell line of mature human adipocytes was incubated with 50 μg/mL lutein for 24 and 48 h, whereafter FD mRNA and protein expression were measured. Results. Lutein significantly inhibited adipocyte FD mRNA expression and FD protein release into adipocyte culture supernatants. Conclusions. Our earlier observations showing that a daily lutein supplement in individuals with early signs of AMD lowered the level of circulating FD might be caused by blocking adipocyte FD production.

Identifiers

PMID26504594
PMCPMC4609459
OpenAlexW1917658802

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.